XST
0.021
133.3%
PAB
0.001
-50%
CZN
0.003
50%
ZMM
0.012
-29.4%
WEL
0.003
50%
MMR
0.005
-28.6%
AMU
0.21
44.8%
1AD
0.003
-25%
MRQ
0.004
33.3%
BUY
0.003
-25%
RAN
0.004
33.3%
TMS
0.006
-25%
SRL
4.43
32.2%
AGD
0.037
-21.3%
AVH
1.905
29.2%
FBR
0.004
-20%
CCE
0.076
28.8%
MEM
0.004
-20%
LMS
0.14
27.3%
ATH
0.01
-16.7%
CLA
0.01
25%
JAY
0.005
-16.7%
SRZ
0.025
25%
SPQ
0.005
-16.7%
RAC
2.2
22.2%
FUN
0.105
-16%
THR
0.011
22.2%
MNC
0.135
-15.6%
ORP
0.039
21.9%
HMG
0.062
-15.1%
T3D
0.195
21.9%
FAL
0.815
-15.1%
BML
0.34
21.4%
LTP
0.595
-14.4%
SBM
0.465
19.2%
PGY
0.006
-14.3%
CXU
0.013
18.2%
RGT
0.1
-13%
COD
0.147
17.6%
TON
0.007
-12.5%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

EZZ Life Science (ASX: EZZ): Targets US expansion followingFDA product approvals

Australian genomic life science company EZZ Life Science (ASX: EZZ) has won approval from the United States (US) Food and Drug Administration (FDA) for nine of its products in the food category, presenting a significant US expansion opportunity for EZZ. | ASX announcement: https://announcements.asx.com.au/asxpdf/20240625/pdf/064x2fh3lh72px.pdf